Lung cancer screening with low-dose chest computed tomography

Recent radiologic advances

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Lung cancer is the leading cause of cancer-related death worldwide. Most patients are diagnosed with advanced disease, resulting in a poor prognosis. Screening may induce the early detection of lung cancer and early detection of lung cancer may reduce lung cancer-related mortality. Recently, the National Lung Screening Trial has demonstrated that lung cancer screening with low-dose chest computed tomography (LDCT) showed a 20% reduction in lung cancer-related mortality and a 6.7% decrease in all-cause mortality in the US. Based on the results of National Lung Screening Trial, various lung cancer-related societies recommend lung cancer screening using LDCT in asymptomatic populations at high risk based on old age and a heavy smoking history. For effective and responsible lung cancer screening, LDCT should be performed at sites providing high-quality low-radiation exposure computed tomography (CT). LDCT must be performed with multidetector helical CT in a single breath-hold and use adequate technical parameters. CT is interpreted accurately by qualified physicians. And structured reporting and management system should be recommended for high quality reporting and medical outcomes monitoring. Adverse events associated with LDCT screening may include a high detection rate of lung nodules and high false positive results, overdiagnosis, and relatively high radiation exposure. However, lung cancer screening with LDCT can result in more benefits than harms when performed in settings with high quality screening programs.

Original languageEnglish
Pages (from-to)523-533
Number of pages11
JournalJournal of the Korean Medical Association
Volume58
Issue number6
DOIs
Publication statusPublished - 2015 Jun 1

Fingerprint

Early Detection of Cancer
Lung Neoplasms
Thorax
Tomography
Lung
Mortality
Multidetector Computed Tomography
Spiral Computed Tomography
Smoking
History
Physicians

Keywords

  • Lung neoplasms
  • Multidetector computed tomography
  • Pulmonary nodule
  • Radiology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lung cancer screening with low-dose chest computed tomography : Recent radiologic advances. / Kang, Eun-Young.

In: Journal of the Korean Medical Association, Vol. 58, No. 6, 01.06.2015, p. 523-533.

Research output: Contribution to journalArticle

@article{2d48de87e09346f7858b88aa4f26b589,
title = "Lung cancer screening with low-dose chest computed tomography: Recent radiologic advances",
abstract = "Lung cancer is the leading cause of cancer-related death worldwide. Most patients are diagnosed with advanced disease, resulting in a poor prognosis. Screening may induce the early detection of lung cancer and early detection of lung cancer may reduce lung cancer-related mortality. Recently, the National Lung Screening Trial has demonstrated that lung cancer screening with low-dose chest computed tomography (LDCT) showed a 20{\%} reduction in lung cancer-related mortality and a 6.7{\%} decrease in all-cause mortality in the US. Based on the results of National Lung Screening Trial, various lung cancer-related societies recommend lung cancer screening using LDCT in asymptomatic populations at high risk based on old age and a heavy smoking history. For effective and responsible lung cancer screening, LDCT should be performed at sites providing high-quality low-radiation exposure computed tomography (CT). LDCT must be performed with multidetector helical CT in a single breath-hold and use adequate technical parameters. CT is interpreted accurately by qualified physicians. And structured reporting and management system should be recommended for high quality reporting and medical outcomes monitoring. Adverse events associated with LDCT screening may include a high detection rate of lung nodules and high false positive results, overdiagnosis, and relatively high radiation exposure. However, lung cancer screening with LDCT can result in more benefits than harms when performed in settings with high quality screening programs.",
keywords = "Lung neoplasms, Multidetector computed tomography, Pulmonary nodule, Radiology",
author = "Eun-Young Kang",
year = "2015",
month = "6",
day = "1",
doi = "10.5124/jkma.2015.58.6.523",
language = "English",
volume = "58",
pages = "523--533",
journal = "Journal of the Korean Medical Association",
issn = "1975-8456",
publisher = "Korean Medical Association",
number = "6",

}

TY - JOUR

T1 - Lung cancer screening with low-dose chest computed tomography

T2 - Recent radiologic advances

AU - Kang, Eun-Young

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Lung cancer is the leading cause of cancer-related death worldwide. Most patients are diagnosed with advanced disease, resulting in a poor prognosis. Screening may induce the early detection of lung cancer and early detection of lung cancer may reduce lung cancer-related mortality. Recently, the National Lung Screening Trial has demonstrated that lung cancer screening with low-dose chest computed tomography (LDCT) showed a 20% reduction in lung cancer-related mortality and a 6.7% decrease in all-cause mortality in the US. Based on the results of National Lung Screening Trial, various lung cancer-related societies recommend lung cancer screening using LDCT in asymptomatic populations at high risk based on old age and a heavy smoking history. For effective and responsible lung cancer screening, LDCT should be performed at sites providing high-quality low-radiation exposure computed tomography (CT). LDCT must be performed with multidetector helical CT in a single breath-hold and use adequate technical parameters. CT is interpreted accurately by qualified physicians. And structured reporting and management system should be recommended for high quality reporting and medical outcomes monitoring. Adverse events associated with LDCT screening may include a high detection rate of lung nodules and high false positive results, overdiagnosis, and relatively high radiation exposure. However, lung cancer screening with LDCT can result in more benefits than harms when performed in settings with high quality screening programs.

AB - Lung cancer is the leading cause of cancer-related death worldwide. Most patients are diagnosed with advanced disease, resulting in a poor prognosis. Screening may induce the early detection of lung cancer and early detection of lung cancer may reduce lung cancer-related mortality. Recently, the National Lung Screening Trial has demonstrated that lung cancer screening with low-dose chest computed tomography (LDCT) showed a 20% reduction in lung cancer-related mortality and a 6.7% decrease in all-cause mortality in the US. Based on the results of National Lung Screening Trial, various lung cancer-related societies recommend lung cancer screening using LDCT in asymptomatic populations at high risk based on old age and a heavy smoking history. For effective and responsible lung cancer screening, LDCT should be performed at sites providing high-quality low-radiation exposure computed tomography (CT). LDCT must be performed with multidetector helical CT in a single breath-hold and use adequate technical parameters. CT is interpreted accurately by qualified physicians. And structured reporting and management system should be recommended for high quality reporting and medical outcomes monitoring. Adverse events associated with LDCT screening may include a high detection rate of lung nodules and high false positive results, overdiagnosis, and relatively high radiation exposure. However, lung cancer screening with LDCT can result in more benefits than harms when performed in settings with high quality screening programs.

KW - Lung neoplasms

KW - Multidetector computed tomography

KW - Pulmonary nodule

KW - Radiology

UR - http://www.scopus.com/inward/record.url?scp=84933046939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933046939&partnerID=8YFLogxK

U2 - 10.5124/jkma.2015.58.6.523

DO - 10.5124/jkma.2015.58.6.523

M3 - Article

VL - 58

SP - 523

EP - 533

JO - Journal of the Korean Medical Association

JF - Journal of the Korean Medical Association

SN - 1975-8456

IS - 6

ER -